EUVIMEDEUVIMED entdecken
Crossref

NAD + or β-hydroxybutyrate each protects against tachypacing-induced metabolic remodeling through regulation of mitophagy in HL-1 cardiomyocytes

Xi Qi iD, Liangyu Hu iD, Alexia van Rinsum iD, Werner J H Koopman iD, Jaap Keijer iD, Deli Zhang iD

American Journal of Physiology-Cell Physiology · 2026

DOI: 10.1152/ajpcell.00253.2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2026. Verfasst von Xi Qi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Human and Animal Physiology, Wageningen University & Research, Wageningen, The Netherlands. Hauptthemen laut MEDLINE: Mitophagy, Myocytes, Cardiac, 3-Hydroxybutyric Acid, NAD. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Dutch Research Council VENI talent grant, Dutch Heart Foundation Dekker Senior Scientist Grant, China Scholarship Council (CSC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotinamide adenine dinucleotide and β-hydroxybutyrate restore mitochondrial function and metabolic balance, in part by preserving PINK1-Parkin-MFN2-mediated mitophagy. Silencing key mitophagy regulators abolishes these protective effects, identifying mitophagy as a central mechanism linking metabolic interventions to functional recovery and as a potential therapeutic target in atrial fibrillation-associated remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyMyocytes, Cardiac3-Hydroxybutyric AcidNADMitochondria, HeartAnimalsMiceMetabolic ReprogrammingCell LineEnergy MetabolismOxidative StressGlycolysisSignal TransductionUbiquitin-Protein Ligases

Stichwörter der Autor:innen

NAD+atrial fibrillationmetabolic remodelingmitophagyβOHB

Substanzen

3-Hydroxybutyric AcidNADUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Human and Animal Physiology, Wageningen University & Research, Wageningen, The Netherlands.
  • Department of Pediatrics, Amalia Children's Hospital, Radboud University Medical Center (Radboudumc), Nijmegen, The Netherlands.
  • Radboud Center for Mitochondrial Medicine (RCMM), Radboud University Medical Center (Radboudumc), Nijmegen, The Netherlands.

ORCID-Profile: Xi Qi, Liangyu Hu, Alexia van Rinsum, Werner J H Koopman, Jaap Keijer, Deli Zhang

Förderung

  • Dutch Research Council VENI talent grant
  • Dutch Heart Foundation Dekker Senior Scientist Grant
  • China Scholarship Council (CSC)

Zitieren

APA

Qi, X., Hu, L., Rinsum, A. V., Koopman, W. J. H., Keijer, J., & Zhang, D. (2026). NAD + or β-hydroxybutyrate each protects against tachypacing-induced metabolic remodeling through regulation of mitophagy in HL-1 cardiomyocytes. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00253.2026

Vancouver

Qi X, Hu L, Rinsum AV, Koopman WJH, Keijer J, Zhang D. NAD + or β-hydroxybutyrate each protects against tachypacing-induced metabolic remodeling through regulation of mitophagy in HL-1 cardiomyocytes. American Journal of Physiology-Cell Physiology. 2026. doi:10.1152/ajpcell.00253.2026

BibTeX
@article{Qi2026,
  author = {Qi, Xi and Hu, Liangyu and Rinsum, Alexia van and Koopman, Werner J H and Keijer, Jaap and Zhang, Deli},
  title = {NAD + or β-hydroxybutyrate each protects against tachypacing-induced metabolic remodeling through regulation of mitophagy in HL-1 cardiomyocytes},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2026},
  doi = {10.1152/ajpcell.00253.2026}
}
Kostenlos starten →